Loading clinical trials...
Loading clinical trials...
Portal hypertension is a common and serious complication of liver cirrhosis, often leading to life-threatening conditions such as variceal bleeding, ascites, and hepatic encephalopathy.
Early detection and management are crucial for improving patient outcomes. While invasive methods such as hepatic venous pressure gradient (HVPG) measurement are the gold standard for diagnosis, they are costly and not widely available. Ultrasound, particularly Doppler imaging, offers a non-invasive, cost- effective alternative for assessing portal hypertension.This study aims to determine the frequency of portal hypertension among patients with cirrhotic liver using ultrasound.
Age
20 - 60 years
Sex
ALL
Healthy Volunteers
No
Sheikh Zayed college/hospital
Rahim Yar Khan, Punjab Province, Pakistan
Start Date
March 17, 2025
Primary Completion Date
September 1, 2025
Completion Date
February 28, 2026
Last Updated
July 4, 2025
150
ACTUAL participants
Portal Hypertension diagnostics
DIAGNOSTIC_TEST
Lead Sponsor
Superior University
NCT07343037
NCT05982769
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03208868